Is Eurobio Scientific SA halal to invest in?

According to Musaffa's Shariah screening methodology, Eurobio Scientific SA (ALERS.PA) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Eurobio Scientific SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Eurobio Scientific SA using these criteria to determine its compliance status.

Can Muslims buy shares of Eurobio Scientific SA?

Muslim investors may consider investing in Eurobio Scientific SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Eurobio Scientific SA classified as HALAL?

Musaffa determines the Shariah status of Eurobio Scientific SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Eurobio Scientific SA updated?

The Shariah compliance status of Eurobio Scientific SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Eurobio Scientific SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Eurobio Scientific SA?

You can check the latest Shariah compliance status of Eurobio Scientific SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Eurobio Scientific SA ALERS.PA

€21.50 €0.10 (0.46%) 1D

Last Updated: May 15, 12:00 AM·XPAR

ALERS.PA Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: February 04, 2026

Report Source: 2025 2nd Quarter Report

Analyst's Ratings for Eurobio Scientific SA (ALERS.PA)

Based on 9 analysts giving stock ratings to Eurobio Scientific SA in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Eurobio Scientific SA. Stock Analysis ALERS.PA

France Health Care Micro Cap Report: Q2, 2025

Eurobio-Scientific SA provides in vitro diagnostics solutions. The company is engaged in activities ranging from discovery to the commercialization of specialty diagnostic products. The firm owns a portfolio of diagnostic products in three specialty areas: infectious diseases; Alzheimer's disease, and cancer. The company consists of Tetanos Quick Stick (TQS), which is an unitary test enabling to determine the tetanus vaccination status. The company has a portfolio of in-house and co-developed products, including AclarusDx (a blood-based test for the detection of biomarkers specific for Alzheimer's disease). The portfolio includes BJI Inoplex for prosthetic infections and EHT Dx14 for breast cancer (both in validation phase). The co-developed products include research programs for the identification of predictive biomarkers of response for anti-HER2 and anti-angiogenic therapies, among others. The company operates through Genbio and Eurobio Capforce Plus.

Key Statistics of Eurobio Scientific SA (ALERS.PA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€21.50€21.60

Today's Open

€21.60

Volume

89.00

P/E Ratio (TTM)

44.62

52 Week Range

€20.40€25.95

Market Cap

225.12M

Avg. Volume

1244.32

Dividend Yield

Financial Metrics & Statements of Eurobio Scientific SA (ALERS.PA)

FAQ's for Eurobio Scientific SA (ALERS.PA)

According to Musaffa’s Shariah screening methodology, Eurobio Scientific SA (ALERS.PA) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.